Currently, miR-21 has been reported in several articles and is associated with disease progression in colon cancer, breast cancer, renal fibrosis, cardiac fibrosis by targeting PTEN, PDCD4, SMAD7 and SPRY, and others [38–41]. Here, SMAD7 is linked to breast cancer.